Atlas Trials

A Study in Healthy Male Participants to Compare How CHF10196 Affects How the Body Absorbs and Processes Two Commonly Used Medicines: Dabigatran, a Blood Thinner, and Rosuvastatin, a Medicine Used to Lower Cholesterol

Clinical trial NCT07744386 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07744386
Sponsor
Chiesi Farmaceutici S.p.A.
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Male Volunteers
Start date
2026-10-27
Primary completion
2028-12-15
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.